| ST002942 Targeted analysis of short chain fatty acids for the XMaS clinical trial. | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| Amino Sugar Metabolism (1) | SMP0000045 | map00520 |
| Aspartate Metabolism (1) | SMP0000067 | map00250 |
| Butyrate Metabolism (1) | SMP0000073 | map00650 |
| Ethanol Degradation (1) | SMP0000449 | - |
| Fatty Acid Biosynthesis (2) | SMP0000456 | - |
| Gluconeogenesis (1) | SMP0000128 | map00010 |
| Propanoate Metabolism (1) | SMP0000016 | map00640 |
| Pyruvate Metabolism (2) | SMP0000060 | map00620 |
| Vitamin K Metabolism (1) | SMP0000464 | - |
| Warburg Effect (1) | SMP0000654 | - |
